Lindi Chen

447 total citations
8 papers, 338 citations indexed

About

Lindi Chen is a scholar working on Neurology, Oncology and Cancer Research. According to data from OpenAlex, Lindi Chen has authored 8 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Lindi Chen's work include Neuroblastoma Research and Treatments (8 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cancer-related Molecular Pathways (4 papers). Lindi Chen is often cited by papers focused on Neuroblastoma Research and Treatments (8 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cancer-related Molecular Pathways (4 papers). Lindi Chen collaborates with scholars based in United Kingdom, Italy and United States. Lindi Chen's co-authors include Deborah A. Tweddle, John Lunec, Katrina Wood, Tao Liu, Emma Bell, Glenn M. Marshall, Nunzio Iraci, Laura D. Gamble, Giovanni Perini and Samuele Gherardi and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Lindi Chen

8 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lindi Chen United Kingdom 6 209 207 136 134 30 8 338
Anneleen Decock Belgium 8 96 0.5× 282 1.4× 33 0.2× 218 1.6× 16 0.5× 15 352
Hannah Webber United Kingdom 6 98 0.5× 119 0.6× 65 0.5× 78 0.6× 21 0.7× 10 242
Harriet Southgate United Kingdom 4 37 0.2× 230 1.1× 131 1.0× 41 0.3× 15 0.5× 4 288
Maike Effern Germany 5 49 0.2× 153 0.7× 131 1.0× 55 0.4× 12 0.4× 7 297
Valeria Colicchia Italy 10 47 0.2× 267 1.3× 151 1.1× 59 0.4× 62 2.1× 12 335
Gregory C. Howard United States 9 24 0.1× 402 1.9× 91 0.7× 53 0.4× 29 1.0× 14 468
Regina Lin United States 9 26 0.1× 141 0.7× 119 0.9× 88 0.7× 17 0.6× 13 314
Manuela Hugle Germany 11 25 0.1× 263 1.3× 107 0.8× 41 0.3× 14 0.5× 14 365
Jamie F. Conklin United States 5 18 0.1× 290 1.4× 176 1.3× 46 0.3× 23 0.8× 5 375
Barbara Martins Da Costa United Kingdom 3 33 0.2× 90 0.4× 100 0.7× 36 0.3× 37 1.2× 5 198

Countries citing papers authored by Lindi Chen

Since Specialization
Citations

This map shows the geographic impact of Lindi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lindi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lindi Chen more than expected).

Fields of papers citing papers by Lindi Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lindi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lindi Chen. The network helps show where Lindi Chen may publish in the future.

Co-authorship network of co-authors of Lindi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Lindi Chen. A scholar is included among the top collaborators of Lindi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lindi Chen. Lindi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Chen, Lindi, Mark Brougham, Guy Makin, et al.. (2019). Detection of Circulating and Disseminated Neuroblastoma Cells Using the ImageStream Flow Cytometer for Use as Predictive and Pharmacodynamic Biomarkers. Clinical Cancer Research. 26(1). 122–134. 29 indexed citations
2.
Chen, Lindi, Fabio Pastorino, Philip Berry, et al.. (2018). Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma. International Journal of Cancer. 144(12). 3146–3159. 26 indexed citations
3.
Chen, Lindi, et al.. (2018). Characterisation of the p53 pathway in cell lines established from TH-MYCN transgenic mouse tumours. International Journal of Oncology. 52(3). 967–977. 3 indexed citations
4.
Chen, Lindi, Fabio Pastorino, Philip Berry, et al.. (2017). Abstract LB-300: In vivo evaluation of the intravenous MDM2-p53 antagonist RO6839921 alone and in combination with temozolomide in TP53 wild-type orthotopic models of neuroblastoma. Cancer Research. 77(13_Supplement). LB–300. 1 indexed citations
5.
Chen, Lindi, Raphaël F. Rousseau, Steven A. Middleton, et al.. (2015). Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma. Oncotarget. 6(12). 10207–10221. 62 indexed citations
6.
Chen, Lindi, Nunzio Iraci, Samuele Gherardi, et al.. (2010). p53 Is a Direct Transcriptional Target of MYCN in Neuroblastoma. Cancer Research. 70(4). 1377–1388. 98 indexed citations
7.
Bell, Emma, Lindi Chen, Tao Liu, et al.. (2010). MYCN oncoprotein targets and their therapeutic potential. Cancer Letters. 293(2). 144–157. 83 indexed citations
8.
Chen, Lindi, Archie J. Malcolm, Katrina Wood, et al.. (2007). p53 is Nuclear and Functional in Both Undifferentiated and Differentiated Neuroblastoma. Cell Cycle. 6(21). 2685–2696. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026